Département de Chimie-Biologie, Université du Québec à Trois-Rivières, 3351 Boulevard des Forges, QC G9A 5H7, Canada.
Neural Plast. 2012;2012:569149. doi: 10.1155/2012/569149. Epub 2012 May 20.
Phospholipases A₂ (PLA₂s) represent one of the largest groups of lipid-modifying enzymes. Over the years, significant advances have been made in understanding their potential physiological and pathological functions. Depending on their calcium requirement for activation, PLA₂s are classified into calcium dependent and independent. This paper mainly focuses on brain calcium-independent PLA₂ (iPLA₂) and on the mechanisms by which they influence neuronal function and regulate synaptic plasticity. Particular attention will be given to the iPLA₂γ isoform and its role in the regulation of synaptic glutamate receptors. In particular, the paper discusses the possibility that brain iPLA₂γ deficiencies could destabilise normal synaptic operation and might contribute to the aetiology of some brain disorders. In this line, the paper presents new data indicating that iPLA₂γ deficiencies accentuate AMPA receptor destabilization and tau phosphorylation, which suggests that this iPLA₂ isoform should be considered as a potential target for the treatment of Tau-related disorders.
磷脂酶 A₂(PLA₂s)是最大的脂质修饰酶组之一。多年来,人们在理解其潜在的生理和病理功能方面取得了重大进展。根据其激活所需的钙离子,PLA₂s 分为依赖钙离子和非依赖钙离子两种。本文主要关注脑非钙离子依赖型 PLA₂(iPLA₂),以及它们影响神经元功能和调节突触可塑性的机制。特别关注 iPLA₂γ同工型及其在调节突触谷氨酸受体中的作用。本文特别讨论了脑 iPLA₂γ缺乏是否会破坏正常的突触功能,以及是否会导致某些脑疾病的病因。在这方面,本文提出了新的数据,表明 iPLA₂γ缺乏会加剧 AMPA 受体的不稳定性和 tau 磷酸化,这表明这种 iPLA₂同工型应被视为治疗 Tau 相关疾病的潜在靶点。